The accumulation of amyloid-β (Aβ) is a pathological hallmark of AD, with Aβ being produced through the cleavage of amyloid precursor protein (APP) by β-and γ-secretases, generating peptides of Aβ of varying length (Murphy and LeVine, 2010). This evidence concerns the gene APP and Alzheimer disease.